Cetera Investment Advisers Makes New Investment in Grail, Inc. (NASDAQ:GRAL)

Cetera Investment Advisers purchased a new stake in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 17,414 shares of the company's stock, valued at approximately $311,000. Cetera Investment Advisers owned approximately 0.05% of Grail at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new stake in shares of Grail during the fourth quarter worth about $244,000. Moloney Securities Asset Management LLC acquired a new position in Grail during the 4th quarter valued at about $559,000. Rhumbline Advisers bought a new stake in Grail during the 4th quarter worth approximately $456,000. abrdn plc purchased a new stake in shares of Grail in the fourth quarter worth approximately $3,768,000. Finally, Perigon Wealth Management LLC purchased a new position in shares of Grail during the fourth quarter valued at approximately $260,000.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the stock. Morgan Stanley boosted their price target on shares of Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a report on Tuesday, March 18th. Canaccord Genuity Group boosted their target price on Grail from $32.00 to $43.00 and gave the stock a "buy" rating in a research note on Wednesday, May 14th.

Insider Activity at Grail

In other Grail news, President Joshua J. Ofman sold 2,109 shares of the business's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $65,800.80. Following the sale, the president now directly owns 559,673 shares in the company, valued at $17,461,797.60. The trade was a 0.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Aaron Freidin sold 1,816 shares of the stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $56,659.20. Following the transaction, the chief financial officer now owns 335,170 shares of the company's stock, valued at $10,457,304. The trade was a 0.54% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 194,948 shares of company stock worth $6,583,130. Insiders own 1.85% of the company's stock.

Grail Price Performance

Shares of NASDAQ GRAL traded up $1.46 during mid-day trading on Wednesday, reaching $40.01. 1,135,757 shares of the company's stock were exchanged, compared to its average volume of 1,258,175. The firm has a 50-day moving average price of $32.44 and a two-hundred day moving average price of $28.72. The firm has a market capitalization of $1.44 billion and a price-to-earnings ratio of -0.66. Grail, Inc. has a 52 week low of $12.33 and a 52 week high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last released its earnings results on Tuesday, May 13th. The company reported ($3.10) earnings per share for the quarter, beating analysts' consensus estimates of ($4.03) by $0.93. The company had revenue of $31.84 million during the quarter, compared to analysts' expectations of $35.80 million. As a group, sell-side analysts forecast that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Grail Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.